芬戈利莫德治疗患者的基质质:病例报告和范围审查
Vítor Falcão de Oliveira1, Guilherme Diogo da Silva2, Larissa Teixeira Silva2
1Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Departamento de Moléstias Infecciosas e Parasitárias, São Paulo, São Paulo, Brazil.
Revista do Instituto de Medicina Tropical de Sao Paulo
|July 25, 2024
概括
用于多发性硬化症的芬戈利莫德可能会增加发生深层真菌感染 - - 组织等离子体感染的风险. 对于接受fingolimod治疗的患者来说,早期诊断和伊特拉可纳治疗至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 神经学 神经学
- 菌类学 菌类学是指菌类学.
背景情况:
- 芬戈利莫德是一种用于多发性硬化症的斯芬戈-1-酸盐受体调节剂.
- 它与加密球菌脑膜炎的关联是已知的,但其他深层真菌菌的风险尚不清楚.
更多相关视频
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
10.5K
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
3.4K
